In addition, circulating FGF-21 levels at baseline have been shown to predict the development of metabolic diseases in different populations [7–9], indicating that FGF-21 can also be used as a screening and diagnostic biomarker for metabolic diseases [10]. Here, FGF21 is linked to Other metabolic disease.